The provider report
ARSYNL Rx sermorelin review
The current one-month plan is $169.99 billed monthly. A separate three-month plan is $160 per month with $480 billed once. These current labeled plans replace the previously unqualified $249 figure.
The published price
- Formulation
- injection
- Published medication details
- 0.9 mg/mL in a 10 mL vial (9 mg total)
- Billing arrangement
- a recurring rate
On this page
Pricing and billing terms
ARSYNL Rx lists sermorelin at $169.99 per month as a recurring rate. Published treatment details: 0.9 mg/mL in a 10 mL vial; administration individualized. Confirm whether your prescribed treatment, consultations and any required labs are included before enrolling.
- Advertised amount
- $169.99
- Price type
- a recurring rate
- Billing basis
- per month
- Published treatment details
- 0.9 mg/mL in a 10 mL vial; administration individualized
- Included services
- provider consultation; medication; lab monitoring; provider follow-up
The current one-month plan is $169.99 billed monthly. A separate three-month plan is $160 per month with $480 billed once. These current labeled plans replace the previously unqualified $249 figure.
The return policy says prescription sales become final after payment and handover to the carrier. It permits account changes or subscription cancellation before shipping and directs damaged or lost medication questions to patient care. That wording does not guarantee a refund after the pharmacy has prepared medication.
When comparing the stated supply, distinguish vial strength, quantity and prescribed dose. Check separate fees with our guide to what a quoted price includes. To compare billing periods, use the monthly cost calculator. For payment questions, see insurance, HSA and FSA considerations.
What is published
- Published billing$169.99 per month; a recurring rate.
- Medication quantity0.9 mg/mL in a 10 mL vial (9 mg total)
- Included servicesprovider consultation; medication; lab monitoring; provider follow-up
- Formulationinjection
What to confirm
- Dispensing pharmacyRequest the pharmacy’s name and contact details before ordering.
- State availabilityConfirm product eligibility and pharmacy shipping for your address.
Care, enrollment and cancellation
ARSYNL Rx now lists an injection preparation at 0.9 mg per mL in a 10 mL vial. That describes 9 mg total by arithmetic; the clinician determines the individual administration dose. The page describes consultation, medication, follow-up laboratory monitoring and provider check-ins.
It identifies dispensing through a licensed pharmacy partner but does not name the pharmacy assigned to this prescription. A treatment-specific state roster and the exact tests included in monitoring were not established; confirm both before enrolling.
Before your first payment, review cancellation and refund terms. For assessment and testing charges, see what to ask before paying for blood tests.
Pharmacy and availability
- Published medication details
- 0.9 mg/mL in a 10 mL vial (9 mg total)
- Formulations
- injection
- State availability
- No product-specific state list verified. Confirm eligibility and pharmacy shipping for your address.
- Insurance, HSA and FSA
- No coverage terms verified. Ask the provider and your plan administrator before assuming reimbursement.
- Dispensing pharmacy
- No dispensing pharmacy confirmed for this product. Request its name and contact details before ordering.
Formulations and prescribed quantities can differ between providers. An oral product, an injection and a nasal spray should not be assumed interchangeable. Review the evidence on non-injectable forms and discuss the specific product with your clinician.
To identify the pharmacy behind a prescription, review what to check about the compounder. Confirm product-specific availability using our guide to state and shipping restrictions.
Pricing transparency
ARSYNL Rx scores 85 out of 100 on published pricing information. This measures disclosure of price, supply, inclusions and availability. It is not a rating of medical care, safety or treatment effectiveness.
The disclosure score follows our published review methodology.
Scroll the table sideways for the remaining columns.
| What is scored | Earned | Out of | What the page shows |
|---|---|---|---|
| What kind of figure it publishes | 40 | 40 | $169.99, a standing rate the seller will charge again |
| States the billing cycle | 15 | 15 | “per month”, in the seller’s own words |
| States how much drug the price buys | 15 | 15 | 0.9 mg/mL in a 10 mL vial (9 mg total) |
| Itemizes what the price includes | 10 | 10 | provider consultation; medication; lab monitoring; provider follow-up |
| Names a pharmacy on a sermorelin page | 0 | 10 | no compounder named on any sermorelin page we read |
| States the states it serves | 0 | 5 | no state list on the page we read |
| Leaves no unlabeled figure on the page | 5 | 5 | every figure on the page carries what it is |
| Total | 85 | 100 | Higher means more pricing information is available publicly. |
The score summarizes published pricing details. It does not measure clinical quality, safety or treatment effectiveness.